CN108699113A - 肽及其作为抗病毒剂的用途 - Google Patents

肽及其作为抗病毒剂的用途 Download PDF

Info

Publication number
CN108699113A
CN108699113A CN201680079962.8A CN201680079962A CN108699113A CN 108699113 A CN108699113 A CN 108699113A CN 201680079962 A CN201680079962 A CN 201680079962A CN 108699113 A CN108699113 A CN 108699113A
Authority
CN
China
Prior art keywords
peptide
amino acid
site
influenza
prt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680079962.8A
Other languages
English (en)
Chinese (zh)
Inventor
M·R·穆罕默德易卜拉欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vera Matisse Pte Ltd
Original Assignee
Vera Matisse Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vera Matisse Pte Ltd filed Critical Vera Matisse Pte Ltd
Publication of CN108699113A publication Critical patent/CN108699113A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201680079962.8A 2015-11-27 2016-11-28 肽及其作为抗病毒剂的用途 Pending CN108699113A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides
MYPI2015002751 2015-11-27
US201662335201P 2016-05-12 2016-05-12
US62/335,201 2016-05-12
US201662425913P 2016-11-23 2016-11-23
US62/425,913 2016-11-23
PCT/IB2016/057146 WO2017090010A1 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Publications (1)

Publication Number Publication Date
CN108699113A true CN108699113A (zh) 2018-10-23

Family

ID=58763140

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680079962.8A Pending CN108699113A (zh) 2015-11-27 2016-11-28 肽及其作为抗病毒剂的用途

Country Status (7)

Country Link
US (1) US10538554B2 (enExample)
EP (1) EP3380493A4 (enExample)
JP (2) JP2019506840A (enExample)
CN (1) CN108699113A (enExample)
AU (1) AU2016359545B2 (enExample)
MY (2) MY184269A (enExample)
WO (1) WO2017090010A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110869040A (zh) * 2017-05-26 2020-03-06 维拉马蒂斯私人有限公司 肽及其用作抗病毒剂的用途

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115244067A (zh) * 2019-08-29 2022-10-25 Ajk生物制药有限责任公司 合成抗微生物肽
CN111100194B (zh) * 2020-02-21 2022-03-25 佛山科学技术学院 一种抗菌肽pd-l4在抑制禽流感病毒中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040529A1 (en) * 2007-09-28 2009-04-02 Ulive Enterprises Limited Bacterial vaccine
US20130190228A1 (en) * 2008-06-13 2013-07-25 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus
US20130205416A1 (en) * 2010-07-28 2013-08-08 Anthony Nash Anti-viral agent
CN103360469A (zh) * 2004-05-04 2013-10-23 诺维信阿德宁生物技术公司 抗微生物多肽

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4307841B2 (ja) * 2001-03-22 2009-08-05 アメリカ合衆国 グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
MX2007015105A (es) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Formulacion de vacuna de influenza a base de peptido.
CA2624153A1 (en) 2005-09-29 2007-04-12 The Scripps Research Institute Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family
MY160435A (en) * 2008-06-12 2017-03-15 Univ Putra Malaysia A novel antiviral peptide against avian influenza virus h9n2
BR112014013853A2 (pt) * 2011-12-09 2020-01-14 Ceres Inc uso de um ácido nucleico isolado, método de obtenção de uma célula vegetal transgênica, método de obtenção de uma planta transgênica, método de produção de uma planta, método de produção de biomassa, método de processamento de biomassa, método de alteração da composição de biomassa, método de modulação de composição de biomassa, método de produção de um produto de forragem
EP3013425B1 (en) * 2013-06-27 2020-09-09 Rutgers, the State University of New Jersey Leukotoxin for use in the treatment of ocular disease
KR20200012894A (ko) * 2017-05-26 2020-02-05 비라매틱스 에스디엔 비에이치디 펩타이드 및 항바이러스제로서의 이의 용도

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103360469A (zh) * 2004-05-04 2013-10-23 诺维信阿德宁生物技术公司 抗微生物多肽
WO2009040529A1 (en) * 2007-09-28 2009-04-02 Ulive Enterprises Limited Bacterial vaccine
US20130190228A1 (en) * 2008-06-13 2013-07-25 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus
US20130205416A1 (en) * 2010-07-28 2013-08-08 Anthony Nash Anti-viral agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DEEPAK T. NAIR等: ""Mimicry of Native Peptide Antigens by the Corresponding Retro-Inverso Analogs Is Dependent on Their Intrinsic Structure and Interaction Propensities"", 《THE JOURNAL OF IMMUNOLOGY》 *
MOHAMED RAJIK等: ""Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2"", 《VIROLOGY JOURNAL》 *
YANWEI ZHONG等: ""Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A"", 《VIROLOGY JOURNAL》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110869040A (zh) * 2017-05-26 2020-03-06 维拉马蒂斯私人有限公司 肽及其用作抗病毒剂的用途

Also Published As

Publication number Publication date
US10538554B2 (en) 2020-01-21
EP3380493A4 (en) 2019-07-31
AU2016359545A1 (en) 2018-07-12
MY184269A (en) 2021-03-30
AU2016359545B2 (en) 2021-06-10
MY189021A (en) 2022-01-19
EP3380493A1 (en) 2018-10-03
US20180346516A1 (en) 2018-12-06
WO2017090010A1 (en) 2017-06-01
JP2022088370A (ja) 2022-06-14
JP2019506840A (ja) 2019-03-14

Similar Documents

Publication Publication Date Title
EP2376100B1 (en) Peptidomimetic macrocycles
Garten et al. Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics
Liu et al. Characteristics of human infection with avian influenza viruses and development of new antiviral agents
Leneva et al. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol
JP2021046436A (ja) ペプチド模倣大環状分子およびその製剤
CN101848719B (zh) 流感抑制组合物和方法
Lin et al. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin
JP2022088370A (ja) 抗ウイルス剤としてのペプチドおよびこのための使用
Wu et al. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice
To et al. Beyond channel activity: protein-protein interactions involving viroporins
Tonelli et al. Fight against H1N1 influenza A virus: recent insights towards the development of druggable compounds
CN104151403B (zh) 一类多肽或其衍生物、及其在流感病毒感染中的应用
Astrahan et al. Resistance characteristics of influenza to amino-adamantyls
Galloway et al. Activation of the hemagglutinin of influenza viruses
US9221874B2 (en) Antiviral peptides against influenza virus
JP7233737B2 (ja) ペプチドおよび抗ウイルス剤としてのその使用
Li et al. Advances in Discovery and Design of Anti-influenza Virus Peptides
CN103965292B (zh) 乙型脑炎病毒包膜蛋白结合肽的结构与用途
Pizzorno Mechanisms of resistance to neuraminidase inhibitors in influenza A viruses and evaluation of combined antiviral therapy
Wu et al. Pterostilbene inhibits influenza virus infection through interaction with NS1 protein
Scala Design and synthesis of peptides involved in the inhibition of influenza virus infection
Raj et al. Current Research in Pharmacology and Drug Discovery
Colpitts Characterization of the Mechanisms of Broad-Spectrum Viral Entry Inhibitors
Rajik et al. Novel Anti-viral Peptide Against Avian Infl uenza Virus H9N2
HK40025030A (en) Peptides and uses therefor as antiviral agents

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination